tradingkey.logo
tradingkey.logo
Search

Enlaza Therapeutics Strategic Collaboration With Vertex Pharmaceuticals To Develop War-Lock Drug Conjugates And T-Cell Engagers

ReutersSep 2, 2025 4:52 PM
facebooktwitterlinkedin

- Vertex Pharmaceuticals Inc VRTX.O:

  • ENLAZA THERAPEUTICS: STRATEGIC COLLABORATION WITH VERTEX PHARMACEUTICALS TO DEVELOP WAR-LOCK DRUG CONJUGATES AND T-CELL ENGAGERS

  • ENLAZA: WILL RECEIVE $45 MILLION INCLUSIVE OF AN UPFRONT PAYMENT AND EQUITY INVESTMENT

  • ENLAZA: FURTHER ELIGIBLE TO RECEIVE MORE THAN $2 BILLION IN FUTURE MILESTONE PAYMENTS

  • ENLAZA: VERTEX WILL FUND ALL RESEARCH AND DEVELOPMENT COSTS RELATED TO FOUR-YEAR COLLABORATION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI